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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comConclusions: Effective thrombectomy protects myocardial function and functional
capacity, and reduces no-reﬂow and hospitality mortality.ET (n¼178) Non-ET(n¼117) P
No-reﬂow n(%) 28(15.7%) 47(40.2%) <0.001
Hospital mortality(%) 3(1.7%) 7(6%) 0.049
STR70% (n,%) 117(65.7%) 50(42.7%) <0.001TCT-138
OCT evaluation of intensive vs standard manual thrombus aspiration in STEMI
riadh rihani1
1Saint Philibert, LOMME, France
Background: Thrombus aspiration is a well established technique in the sitting of
primary coronary angioplasty for STEMI. However prior OCT studies failed to
demonstrate any thrombus reduction with current thrombectomy catheters. The aim of
our study is to evaluate by OCT the beneﬁce of intensive thrombus aspiration.
Methods: 40 consecutive patients referred to our cathlab for primary coronary
angioplasty were enrolled in this non randomized single center prospective study. Once
TIMI 3 ﬂowwas obtained using a thrombus aspiration catheter (standard care), a ﬁrst run
of OCT is obtained in order to visualise residual thrombus (initial thrombus), then
supplementary aspiration was conducted with an OCT run after every 4 catheter
passages. Aspiration was continued(intensive aspiration) until no further decrease in
thrombus burden was observed by OCT (ﬁnal thrombus). Then one or more stents were
implanted in order to cover the entire lesionwith systematic post dilatation followed by a
ﬁnal OCT study. The primary end point was thrombus volume after standard care Vs
intensive aspiration.
Results: The mean number of aspirations necessary to obtain a TIMI 3 ﬂow was 4. A
mean of 10 more catheter pullbacks were done to obtain the smallest ﬁnal thrombus
volume. At the end of the procedure TIMI 3 ﬂow was present in 39 patients (97%) and
TIMI 3 Blush in 38 (95%). ST segment elevation decreased by more than 70% in 38
patients. Distal embolization occured in 2 patients. On OCT, initial thrombus
volume was 7.07 mm3 vs 3.80 mm3 for ﬁnal thrombus (54% reduction, P< 0.001).
Minor incomplete stent apposition with a mean surface of 0.12 mm2 was seen in
4 patients (10.8%). Intrastent protrusion was constant but minimal 0.33 mm3.
Minimal stent area and minimal ﬂow area were not different (8.28 mm2 vs 7.84mm2,
D ¼ 0.44, p¼0.7). No anemia, kidney injury nor other complications occured during
hospital stay.
Conclusions: The results from our study suggest that intensive manual thrombus
aspiration using a catheter during a primary coronary angioplasty seems to be effective
in reducing the thrombus burden as assessed by OCT. These results have to be
conﬁrmed in large clinical studies.
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Effect of thrombus burden and its residue on no-reﬂow phenomenon after
manual thrombectomy in patients with ST-elevation myocardial infarction
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Background: Large thrombotic burden is a well-known predictor of no-reﬂow phe-
nomenon and mortality in patients with ST-elevation myocardial infarction (STEMI).
However, few data are available on the clinical signiﬁcance of residual thrombus after
thrombectomy. Therefore, we aimed to investigate the efﬁcacy of manual thrombec-
tomy in decreasing thrombus burden, and the effect of residual thrombus on
myocardial perfusion after thrombectomy.
Methods: 416 consecutive STEMI patients undergoing primary percutaneous coro-
nary intervention (PPCI) were studied. The no-reﬂow phenomenon incidence after
PPCI was compared between the small thrombus burden (n¼113) and large thrombus
burden (n¼303) groups, deﬁned by a thrombus score of 4. Aspiration thrombectomy
was performed in 263 (87%) patients in the large thrombus group, and the no-reﬂow
incidence in this group was compared based on thrombectomy treatment and pre-
stenting residual thrombus. No reﬂow phenomenon was deﬁned by a ﬁnal TIMI ﬂow
grade of 2 or myocardial blush grade of 1.
Results: No-reﬂow phenomenon occurred frequently in the large thrombus burden
patients without thrombectomy, followed by those who underwent thrombectomy, and
by the small thrombus burden group (35% vs. 14.8% vs. 8.6%, p< 0.001). Patients
with pre-stenting residual thrombus had a higher no-reﬂow incidence than those
without visible pre-stenting thrombus (79% vs. 22%, p< 0.001). Mutivariate analysis
identiﬁed pre-stenting residual thrombus (OR 2.9, 95% CI 1.9-6.3), balloon pre-
dilatation (OR 1.4, 95% CI 1.1-2.1) and pre-stenting TIMI ﬂow grade of 1 (OR 2.2,
95% CI 1.6-5.7) as independent predictors of no-reﬂow phenomenon.
Conclusions: Manual thrombectomy substantially reduces no-reﬂow phenomenon
incidence in STEMI patients with large thrombus burden. However, residual thrombus
after thrombectomy increases no-reﬂow phenomenon occurrence.B42 JACC Vol 64/11TCT-140
Prognostic value of manual thrombus aspiration in patients undergoing Primary
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Background: Recent studies question the value of manual thrombus aspiration (TA)
before PCI in patiens with ST-segment elevation infarction (STEMI). The aim of this
study was to evaluate the impact of TA in a contemporary cohort of patients admitted
to our hospital with STEMI who were undergoing primary percutaneous coronary
intervention (PPCI).
Methods: We analyzed the data and clinical outcomes of 1044 consecutive patients un-
dergoing PPCI betwen january 2009 and december 2013. We clasiﬁed patients into TA-
PPCI (n¼666) and non TA-PPCI (n¼378). Mean follow-up was 23 months. Primary
endpoint was all cause mortality and secondary endpoint was major adverse cardiovas-
cular events ( MACE; death, recurrent MI, targent vessel revascularization, heart failure).
Results: The median patient age was 65 years, 76,6% were men, 50,1% had hyper-
tension, and 24% had diabetes. Percutaneous access was via the radial approach in
88% of the patients. The variables independently associated whith TA use are: sex,
culprit artery, number of vessel disease and TIMI 0 before PPCI. At the end of the
follow-up 12,5% of the patients died: 11,1% in TA-PPCI group, and 15,1% in non
TAPPCI (p¼0,040)(See Image 1). The incidence of major adverse cardiovascular
events (MACE ) at the end of the follow-up was 23,1%: 21% in TA-PPCI group and
23,7% in non TA-PPCI 0,022 (P¼0.022). However, after cox regression analysis, we
don’t ﬁnd independent association between TA and mortality or MACE
Conclusions: The use of TA in a “real-world” cohort of patients with STEMI who
were undergoing PPCI was not associated with a reduction in mortality or MACE risk.TCT-141
The Randomized Physiologic Assessment of Thrombus Aspiration in Patients
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Background: Routine thrombus aspiration is superior to conventional primary
percutaneous coronary intervention (PCI) in terms of improved myocardial perfusion
in patients with acute myocardial infarction with ST-segment elevation (STEMI).
However, myocardial perfusion after thrombus aspiration has not been evaluated by a
quantitative index of microcirculatory resistance (IMR).
Methods: We performed a randomized, controlled clinical trial to evaluate impact of
manual thrombus aspiration (the Eliminate aspiration catheter, Terumo Medical Supply,
Japan) on microcirculatory resistance after primary PCI in 128 patients with the ﬁrst/Suppl B j September 13–17, 2014 j TCT Abstracts/Thrombectomy


















All-cause death 375(18.6％) 265(22.9％) 0.78(0.67-0.90) <0.001 0.91(0.77-1.09) 0.30
Cardiac death 230(11.3％) 230(11.3％) 0.82(0.68-1.00) 0.049 1.00(0.79-1.26) 0.99
Non-cardiac
death
145(8.2％) 103(10.4％) 0.71(0.56-0.90) 0.005 0.79(0.61-1.03) 0.09
MI 110(5.9％) 71(6.9％) 1.00(0.93-1.08) 0.32 0.89(0.65-1.22) 0.47
Stroke 100(5.4％) 70(6.9％) 0.75(0.56-1.00) 0.052 0.78(0.56-1.09) 0.15
Stent
thrombosis
51(2.7％) 30(2.8％) 0.95(0.62-1.49) 0.82 0.89(0.56-1.42) 0.61
TLR 423(22.2％) 272(25.6％) 0.85(0.73-0.99) 0.033 0.93(0.78-1.10) 0.40
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMSTEMI randomly assigned to thrombus aspiration or conventional primary PCI group
before coronary angiography. The primary endpoint was deﬁned as a signiﬁcant reduction
of IMR in thrombus aspiration compared to conventional PCI group.Myocardial perfusion
grade and resolution of ST-segment elevation were also assessed. Infarct size and left
ventricle remodeling were assessed by echocardiographic indices and SPECT.
Results: Manual thrombus aspiration, as compared with conventional PCI, resulted in
signiﬁcantly lower IMR (31.921.3 U vs. 47.035.8 U, P ¼ 0.0082). Treatment with
thrombus aspiration, as compared with conventional PCI, resulted in similar rates of
myocardial perfusion grade 0 or 1 (20.8% vs. 29.4%; relative risk, 0.71; 95% CI, 0.38
to 1.30; P¼0.26) and complete resolution of ST-segment elevation (59.7% vs. 47.1%;
relative risk, 1.27; 95% CI, 0.90 to 1.79, P¼0.17). In a multiple regression model with
the log-transformed IMR as dependent variable, after adjusting for clinical, angio-
graphic and procedural variables, thrombus aspiration remained a strong independent
predictor of lower IMR (27.14 U; 95% CI, 23.79 to 30.95 U, vs. 36.11 U; 95% CI,
30.74 to 42.41 U, P¼0.0076). Histopathological examination conﬁrmed successful
thrombus aspiration in 89.6% of patients.
Conclusions: Manual thrombus aspiration reduces microcirculatory resistance indi-
cating better myocardial perfusion compared to conventional PCI in patients with
STEMI. Manual thrombus aspiration tended towards improved clinical outcome.
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Thrombus aspiration is similarly effective in STEMI patients with ischemia
lasting less than 6 hours compared to those with longer ischemia: subanalysis of
the PATA STEMI trial
Dejan Orlic1, Dejan Milasinovic1, Milorad Zivkovic1, Milorad Tesic1,
Vladimir Dedovic1, Zlatko Mehmedbegovic1, Branko Beleslin1, Miodrag C. Ostojic2
1Clinical Center of Serbia, Belgrade, Serbia, 2Medical School University of Belgrade,
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Background: It has been reported that thrombus aspiration is effective in STEMI
patients with total ischemic time duration of less than 3 hours and less effective in
longer ischemia. Some studies tested thrombus aspiration efﬁcacy only within 6 hours
from chest pain onset. However, little is known about invasive assessment of
thrombus aspiration efﬁcacy in STEMI patients beyond 6 hours of ischemia.
Methods: Patients who underwent thrombus aspiration were divided into two groups
according to total ischemic time duration:< 6 hours and6 hours. These patients were
taken from the PATA STEMI trial for the analysis. Primary endpoint was value of mean
index of microcirculatory resistance (IMR). Secondary endpoints were myocardial
blush grade (MBG), resolution of ST segment elevation, AUC CK, wall motion score
index (WMSI), left ventricular ejection fraction and MACE rate at one year follow-up.
Results: In the PATA STEMI trial 75 patients underwent manual thrombus aspiration
with the Eliminate3 catheter (Terumo Europe, Leiden, Belgium). In baseline charac-
teristics, patients delay (74,5 vs 377,9, P¼0,00018) and multivessel disease (46,0% vs
83,3%, P¼0,026) were more frequent in patients with total ischemic time 6 hours
(N¼12). In patients with totals ischemic time< 6 hours (N¼63) compared to those with
6 hours, mean IMR was 30,417,8 vs. 36,419,8 U, P¼0,34 (mean corrected IMR
26,515,8 vs. 34,319,9 U, P¼0,22), mean IMR in non-infarct related artery teritory
18,68,0 vs 24,24,0 U, P¼0,21, complete resolution of ST-segment elevation 63,5%
vs. 50%, P¼0,53, myocardial blush grade 2 in 80,9% vs. 66,7%, P¼0,44, AUC CK
4030325380 vs. 4443130316 U/L, P¼0,69, WMSI 1,320,33 vs. 1,180,19,
P¼0,06, LVEF 53,9% vs. 59,3%, P¼0,11 and MACE rate 11,1% vs. 0%, P¼0,59.
Conclusions: Manual thrombus aspiration in STEMI patients with ischemia lasting
less than 6 hours is similarly effective as in those with longer ischemia.
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Impact of manual thrombus aspiration on left ventricular remodeling: the
echocardiographic substudy of the randomized Physiologic Assessment of
Thrombus Aspiration in patients with ST-segment Elevation Myocardial
Infarction (PATA STEMI) trial
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Background: It has been reported that index of microcirculatory resistance (IMR) is
lower in STEMI patients who underwent thrombus aspiration before stent implantation
compared to those tretaed with conventional primary PCI. The aim of this study was to
evaluate impact of improved myocardial perfusion by manual thrombus aspiration
assessed by IMR on left ventricular remodeling in STEMI patients at mid-term follow-up.
Methods: The total of 115 patients entered the echocardiography substudy of the
PATA STEMI (randomized Physiologic Assessment of Thrombus Aspirtion in pa-
tients with ST-segment Elevation Myocardial Infarction) trial which evaluated eﬁcacy
of manual thrombus aspiration using Eliminate3 catheter (Terumo Europe, Leuven,
Belgium). Echocardiography was done within the ﬁrst 24 hours after the index pro-
cedure and after 4 months. End-diastolic and end-systolic left ventricular (LV) vol-
umes, ejection fraction (EF), cardiac sphericity index (CSI) and regional wall motion
score index (WMSI) were calculated.
Results: In baseline characteristics, in patients with thrombus aspiration compared to
those with conventional primary PCI, total ischemic time tended to be longer
246,7181,8 vs. 200,9110,1min, P¼0,09 andAUCCKwas smaller 4009026158U/L
vs. 5267632013 U/L, P¼0,026. Also, corrected IMR was lower in thrombus aspirationJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Cagroup 27,516,8 vs. 39,932,7 U/L, p¼0,0079, while CFR (1,680,81 vs. 1,610,67,
P¼0,6) and mean capilary wedge pressure (20,46,6 vs. 21,47,8 mmHg, P¼0,5) were
similar. End-diastolic and end-systolic LV volumes per body surface area, EF, CSI volume
and WMSI were similar between the thrombus aspiration and no aspiration group at
baseline and at follow-up. At follow-up, percent change in WMSI tended to be greater in
thrombusaspirationgroup (decrease inWMSI8,2%vs. increase inWMSI0,8%,P¼0,094).
Conclusions: Improved myocardial perfusion assessed by IMR has no impact on left
ventricular remodeling in STEMI patients at mid-term follow-up.
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The clinical efﬁcacy of thrombus aspiration on ﬁve-year clinical outcomes in
patients with ST-segment elevation acute myocardial infarction undergoing
percutaneous coronary intervention
HIroki Watanabe1, Hiroki Shiomi2, Takeshi Kimura2
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Background: The use of adjunctive thrombus aspiration (TA) promotes better cor-
onary reperfusion and improves myocardial perfusion in STEMI but the long-term
mortality beneﬁt still remains controversial.
Methods: The CREDO-Kyoto AMI registry is a large-scale cohort study of acute
myocardial infarction (AMI) patients undergoing coronary revascularization in 2005-
2007 at 26 hospitals in Japan. Among 5429 patients enrolled in the registry, the
current study population consisted of 3325 patients who arrived at the hospital within
12 hours after the symptom onset and underwent primary PCI. During primary PCI,
2120 out of 3325 (63.8%) patients received thrombus aspiration (the TA group).
Clinical outcomes were compared between the TA group and the non-TA group.
Results: The cumulativeﬁve-year incidence of all-cause deathwas signiﬁcantly lower in
the TA group than in the non-TA group (18.6% versus 22.6%, P< 0.001). Similarly, the
cumulative incidences of cardiac death, non-cardiac death, and target-lesion revascu-
larization (TLR) were signiﬁcantly lower in the TA group. After adjusting for
confounders, however, the use of adjunctive TA was not associated with lower risk for
all-cause death (hazard ratio [HR]:0.91, 95% conﬁdence interval [CI]:0.77-1.09,
P¼0.30). In contrast, the subgroup analysis indicated TAwas associated with a lower all-
causemortality only in patients with initial TIMI grade 1-3(HR: 0.70, 95%CI:0.52-0.94,
P¼0.02). Adjunctive thrombus aspiration had a neutral effect in the rest of the subgroups.Conclusions: Adjunctive thrombus aspiration was not associated with better ﬁve-year
mortality beneﬁt in STEMI patients who underwent primary PCI.Cath Lab of the Future
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